BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1311930)

  • 1. Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu3, following their expression in Escherichia coli as fusion proteins.
    King R; Wells JR; Krieg P; Snoswell M; Brazier J; Bagley CJ; Wallace JC; Ballard FJ; Ross M; Francis GL
    J Mol Endocrinol; 1992 Feb; 8(1):29-41. PubMed ID: 1311930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency.
    Francis GL; Ross M; Ballard FJ; Milner SJ; Senn C; McNeil KA; Wallace JC; King R; Wells JR
    J Mol Endocrinol; 1992 Jun; 8(3):213-23. PubMed ID: 1378742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
    Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.
    Francis GL; Aplin SE; Milner SJ; McNeil KA; Ballard FJ; Wallace JC
    Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):713-9. PubMed ID: 7688957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.
    Sakano K; Enjoh T; Numata F; Fujiwara H; Marumoto Y; Higashihashi N; Sato Y; Perdue JF; Fujita-Yamaguchi Y
    J Biol Chem; 1991 Nov; 266(31):20626-35. PubMed ID: 1657932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli.
    Forsberg G; Palm G; Ekebacke A; Josephson S; Hartmanis M
    Biochem J; 1990 Oct; 271(2):357-63. PubMed ID: 2173560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level expression and simple purification of recombinant human insulin-like growth factor I.
    Kim SO; Lee YI
    J Biotechnol; 1996 Jul; 48(1-2):97-105. PubMed ID: 8818276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of insulin-like growth factor (IGF) function: production and characterization of recombinant hagfish IGF.
    Upton Z; Francis GL; Chan SJ; Steiner DF; Wallace JC; Ballard FJ
    Gen Comp Endocrinol; 1997 Jan; 105(1):79-90. PubMed ID: 9000470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
    Hodgson DR; May FE; Westley BR
    Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of recombinant chicken insulin-like growth factor-I from Escherichia coli.
    Upton FZ; Francis GL; Ross M; Wallace JC; Ballard FJ
    J Mol Endocrinol; 1992 Aug; 9(1):83-92. PubMed ID: 1515028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of recombinant chicken insulin-like growth factor-II from Escherichia coli.
    Upton Z; Francis GL; Kita K; Wallace JC; Ballard FJ
    J Mol Endocrinol; 1995 Feb; 14(1):79-90. PubMed ID: 7772242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical heterogeneity as a result of hydroxylamine cleavage of a fusion protein of human insulin-like growth factor I.
    Canova-Davis E; Eng M; Mukku V; Reifsnyder DH; Olson CV; Ling VT
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):207-13. PubMed ID: 1637301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of secreted insulin-like growth factor-1 in Escherichia coli.
    Wong EY; Seetharam R; Kotts CE; Heeren RA; Klein BK; Braford SR; Mathis KJ; Bishop BF; Siegel NR; Smith CE
    Gene; 1988 Sep; 68(2):193-203. PubMed ID: 3065142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.
    Lüthi C; Roth BV; Humbel RE
    Eur J Biochem; 1992 Apr; 205(2):483-90. PubMed ID: 1374027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification, and in vitro characterization of recombinant salmon insulin-like growth factor-II.
    Wilkinson RJ; Elliott P; Carragher JF; Francis G
    Protein Expr Purif; 2004 Jun; 35(2):334-43. PubMed ID: 15135411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF)-I.
    Milner SJ; Thomas SM; Ballard FJ; Francis GL
    Biotechnol Bioeng; 1996 May; 50(3):265-72. PubMed ID: 18626954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region.
    Chen JY; Chang CY; Chen JC; Shen SC; Wu JL
    DNA Cell Biol; 1997 Jul; 16(7):883-92. PubMed ID: 9260931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification.
    Moks T; Abrahmsén L; Holmgren E; Bilich M; Olsson A; Uhlén M; Pohl G; Sterky C; Hultberg H; Josephson S
    Biochemistry; 1987 Aug; 26(17):5239-44. PubMed ID: 3676250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67.
    Roth BV; Bürgisser DM; Lüthi C; Humbel RE
    Biochem Biophys Res Commun; 1991 Dec; 181(2):907-14. PubMed ID: 1721812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression of human insulin-like growth factor II in Escherichia coli.
    Rhee HJ; Lee YI; Yang KH
    J Biotechnol; 1990 Mar; 13(4):293-304. PubMed ID: 1366560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.